Literature DB >> 17020664

Venous thromboembolic disease. Clinical practice guidelines in oncology.

Lawrence D Wagman1, Melissa F Baird, Charles L Bennett, Paula L Bockenstedt, Spero R Cataland, John Fanikos, Patrick F Fogarty, Samuel Z Goldhaber, Tejpal S Grover, William Haire, Hani Hassoun, Mohammad Jahanzeb, Lawrence L Leung, Michael L Linenberger, Michael M Millenson, Thomas L Ortel, Riad Salem, Judy L Smith, Michael B Streiff.   

Abstract

Entities:  

Mesh:

Year:  2006        PMID: 17020664     DOI: 10.6004/jnccn.2006.0071

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


× No keyword cloud information.
  13 in total

Review 1.  Venous thromboembolism and cancer: a systematic review.

Authors:  Celso Arrais Rodrigues; Renata Ferrarotto; Roberto Kalil Filho; Yana A S Novis; Paulo M G Hoff
Journal:  J Thromb Thrombolysis       Date:  2010-07       Impact factor: 2.300

2.  Aortic thrombosis resolved with enoxaparin in a patient treated with cisplatin-based regimen for small cell lung cancer.

Authors:  Sang Ouk Chin; Jae Jin Lee; Yeon Hee Hwang; Jae Joon Han; Chi Hoong Maeng; Sun Kyung Baek; Cheong Woong Choi
Journal:  Int J Hematol       Date:  2010-04-29       Impact factor: 2.490

Review 3.  Management of anticoagulation in patients with metastatic castration-resistant prostate cancer receiving abiraterone + prednisone.

Authors:  Samuel Dubinsky; Alia Thawer; Anne G McLeod; Thomas R J McFarlane; Urban Emmenegger
Journal:  Support Care Cancer       Date:  2019-05-10       Impact factor: 3.603

4.  Are There Any Differences in the Clinical and Economic Outcomes Between US Cancer Patients Receiving Appropriate or Inappropriate Venous Thromboembolism Prophylaxis?

Authors:  Alpesh N Amin; Jay Lin; Guiping Yang; Stephen Stemkowski
Journal:  J Oncol Pract       Date:  2009-07       Impact factor: 3.840

Review 5.  The role of thromboprophylaxis in cancer patients: emerging data.

Authors:  Laurel A Menapace; Alok A Khorana
Journal:  Curr Opin Hematol       Date:  2010-09       Impact factor: 3.284

Review 6.  Update on Guidelines for the Management of Cancer-Associated Thrombosis.

Authors:  Michael B Streiff; Syed Ali Abutalib; Dominique Farge; Martina Murphy; Jean M Connors; Gregory Piazza
Journal:  Oncologist       Date:  2020-12-04

7.  Inferior vena cava filters for primary prophylaxis: when are they indicated?

Authors:  Eric Wehrenberg-Klee; S William Stavropoulos
Journal:  Semin Intervent Radiol       Date:  2012-03       Impact factor: 1.513

8.  Development and validation of a predictive model for chemotherapy-associated thrombosis.

Authors:  Alok A Khorana; Nicole M Kuderer; Eva Culakova; Gary H Lyman; Charles W Francis
Journal:  Blood       Date:  2008-01-23       Impact factor: 22.113

Review 9.  New insights into cancer-associated thrombosis.

Authors:  Tarek Sousou; Alok A Khorana
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-03       Impact factor: 8.311

10.  Prevention and treatment of venous thromboembolism in patients with cancer.

Authors:  William M Semchuk; Catherine Sperlich
Journal:  Can Pharm J (Ott)       Date:  2012-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.